The role of riboflavin synthase in CRC development may be due to the activity of microbe-derived riboflavin metabolites in activating mucosal-associated invariant T-Cell (MAIT) in a MR1-dependent manner (59). The gene discussed is MR1; the disease is colorectal carcinoma.